Bicycle Therapeutics plc (BCYC)

Bicycle Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	721.45	879.52	526.42	339.15	438.68	135.99
Cash & Short-Term Investments	721.45	879.52	526.42	339.15	438.68	135.99
Cash Growth	-24.95%	67.07%	55.22%	-22.69%	222.58%	47.63%
Accounts Receivable	-	-	-	2.05	1	5.46
Other Receivables	60.75	35.65	24.04	19.16	10.91	9.18
Receivables	60.75	35.65	24.04	21.21	11.91	14.63
Prepaid Expenses	22.06	13.43	11.41	9.02	7.97	5.1
Total Current Assets	804.26	928.61	561.87	369.38	458.56	155.72
Property, Plant & Equipment	14.11	17.19	27.68	32.77	17.79	3.61
Other Long-Term Assets	13.81	11.07	5.79	8.46	3.45	1.82
Total Assets	832.18	956.87	595.34	410.61	479.79	161.15
Accounts Payable	18.26	15.79	13.05	6.47	2.72	1.37
Accrued Expenses	38.87	35.45	26.38	21.86	11.29	10.58
Current Portion of Leases	5.43	5.5	4.88	3.13	2.38	0.84
Current Unearned Revenue	14.62	10.19	24.98	20.42	19.27	10.14
Other Current Liabilities	0.24	0.3	0.26	1.47	0.57	0.21
Total Current Liabilities	77.42	67.23	69.54	53.34	36.24	23.13
Long-Term Debt	-	-	30.7	30.32	29.87	14.51
Long-Term Leases	1.77	3.99	9.38	10.89	12.08	0.43
Long-Term Unearned Revenue	82.94	91.47	110.22	41.46	52.07	25.02
Other Long-Term Liabilities	1.14	1.12	4.58	3.83	3.28	2.61
Total Liabilities	163.27	163.81	224.41	139.83	133.54	65.69
Common Stock	0.89	0.89	0.55	0.39	0.38	0.27
Additional Paid-In Capital	1,492	1,473	883.45	601.11	567.64	249.95
Retained Earnings	-820.5	-680.79	-511.76	-331.1	-218.38	-151.56
Comprehensive Income & Other	-3.36	0.12	-1.3	0.39	-3.39	-3.19
Total Common Equity	668.92	793.06	370.93	270.78	346.25	95.46
Shareholders' Equity	668.92	793.06	370.93	270.78	346.25	95.46
Total Liabilities & Equity	832.18	956.87	595.34	410.61	479.79	161.15
Total Debt	7.2	9.49	44.96	44.33	44.34	15.78
Net Cash (Debt)	714.25	870.03	481.47	294.83	394.34	120.22
Net Cash Growth	-22.25%	80.70%	63.30%	-25.24%	228.03%	33.24%
Net Cash Per Share	10.32	14.95	13.53	9.94	15.73	6.28
Filing Date Shares Outstanding	69.31	69.2	42.59	30.02	29.6	23.09
Total Common Shares Outstanding	69.25	69.06	42.43	29.87	29.58	21.09
Working Capital	726.84	861.38	492.33	316.04	422.32	132.59
Book Value Per Share	9.66	11.48	8.74	9.06	11.71	4.53
Tangible Book Value	668.92	793.06	370.93	270.78	346.25	95.46
Tangible Book Value Per Share	9.66	11.48	8.74	9.06	11.71	4.53
Machinery	19.4	16.53	16.91	16.24	7.11	5.97
Leasehold Improvements	11.93	10.9	11	10.74	0.81	0.38

Updated Aug 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q